{
  "id": "9f286c325d047121",
  "title": "STAT+: Parabilis Medicines raises $305 million as CEO warms to an IPO",
  "description": "Startup Parabilis Medicines has raised $305 million in new funding, money that will help bring its lead drug for a variety of cancers into late-stage testing.",
  "content": "Startup Parabilis Medicines has raised $305 million in new funding, money that will help bring its lead drug for a variety of cancers into late-stage testing.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/08/parabilis-medicines-biotech-investors-crossover/?utm_campaign=rss",
  "published_at": "2026-01-08T12:00:00+00:00",
  "fetched_at": "2026-01-09T00:23:18.491015+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ipo",
    "drug",
    "ai",
    "arms"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Parabilis Medicines raises $305 million as CEO warms to an IPO",
    "description": "Startup Parabilis Medicines has raised $305 million in new funding, money that will help bring its lead drug for a variety of cancers into late-stage testing.",
    "url": "https://www.statnews.com/2026/01/08/parabilis-medicines-biotech-investors-crossover/?utm_campaign=rss",
    "published": "2026-01-08T12:00:00+00:00",
    "source": "STAT"
  }
}